Table of Contents

1 Study Coverage

• 1.1 BCG Vaccine Sales Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global BCG Vaccine Sales Market Size Growth Rate by Product
  • 1.4.2 Immune BCG
  • 1.4.3 Therapy BCG
• 1.5 Market by End User
  • 1.5.1 Global BCG Vaccine Sales Market Size Growth Rate by End User
  • 1.5.2 Pediatrics
  • 1.5.3 Adults
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global BCG Vaccine Sales Market Size
  • 2.1.1 Global BCG Vaccine Sales Revenue 2014-2025
  • 2.1.2 Global BCG Vaccine Sales Sales 2014-2025
• 2.2 BCG Vaccine Sales Growth Rate by Regions
  • 2.2.1 Global BCG Vaccine Sales Sales by Regions
  • 2.2.2 Global BCG Vaccine Sales Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 BCG Vaccine Sales Sales by Manufacturers
  • 3.1.1 BCG Vaccine Sales Sales by Manufacturers
  • 3.1.2 BCG Vaccine Sales Sales Market Share by Manufacturers
  • 3.1.3 Global BCG Vaccine Sales Market Concentration Ratio (CR5 and HHI)
• 3.2 BCG Vaccine Sales Revenue by Manufacturers
  • 3.2.1 BCG Vaccine Sales Revenue by Manufacturers (2014-2019)
  • 3.2.2 BCG Vaccine Sales Revenue Share by Manufacturers (2014-2019)
• 3.3 BCG Vaccine Sales Price by Manufacturers
• 3.4 BCG Vaccine Sales Manufacturing Base Distribution, Product Types
  • 3.4.1 BCG Vaccine Sales Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers BCG Vaccine Sales Product Type
  • 3.4.3 Date of International Manufacturers Enter into BCG Vaccine Sales Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global BCG Vaccine Sales Sales by Product
• 4.2 Global BCG Vaccine Sales Revenue by Product
• 4.3 BCG Vaccine Sales Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global BCG Vaccine Sales Breakdown Data by End User

6 North America

• 6.1 North America BCG Vaccine Sales by Countries
  • 6.1.1 North America BCG Vaccine Sales Sales by Countries
  • 6.1.2 North America BCG Vaccine Sales Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America BCG Vaccine Sales by Product
• 6.3 North America BCG Vaccine Sales by End User

7 Europe

• 7.1 Europe BCG Vaccine Sales by Countries
  • 7.1.1 Europe BCG Vaccine Sales Sales by Countries
  • 7.1.2 Europe BCG Vaccine Sales Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe BCG Vaccine Sales by Product
• 7.3 Europe BCG Vaccine Sales by End User

8 Asia Pacific

• 8.1 Asia Pacific BCG Vaccine Sales by Countries
  • 8.1.1 Asia Pacific BCG Vaccine Sales Sales by Countries
  • 8.1.2 Asia Pacific BCG Vaccine Sales Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific BCG Vaccine Sales by Product
• 8.3 Asia Pacific BCG Vaccine Sales by End User

9 Central & South America

• 9.1 Central & South America BCG Vaccine Sales by Countries
  • 9.1.1 Central & South America BCG Vaccine Sales Sales by Countries
  • 9.1.2 Central & South America BCG Vaccine Sales Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America BCG Vaccine Sales by Product
• 9.3 Central & South America BCG Vaccine Sales by End User

10 Middle East and Africa

• 10.1 Middle East and Africa BCG Vaccine Sales by Countries
  • 10.1.1 Middle East and Africa BCG Vaccine Sales Sales by Countries
  • 10.1.2 Middle East and Africa BCG Vaccine Sales Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa BCG Vaccine Sales by Product
• 10.3 Middle East and Africa BCG Vaccine Sales by End User

11 Company Profiles

• 11.1 Merck
  • 11.1.1 Merck Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Merck BCG Vaccine Sales Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Merck BCG Vaccine Sales Products Offered
  • 11.1.5 Merck Recent Development
• 11.2 Sanofi Pasteur
  • 11.2.1 Sanofi Pasteur Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Sanofi Pasteur BCG Vaccine Sales Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Sanofi Pasteur BCG Vaccine Sales Products Offered
  • 11.2.5 Sanofi Pasteur Recent Development
• 11.3 Japan BCG Lab
  • 11.3.1 Japan BCG Lab Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Japan BCG Lab BCG Vaccine Sales Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Japan BCG Lab BCG Vaccine Sales Products Offered
  • 11.3.5 Japan BCG Lab Recent Development
• 11.4 China National Biotec
  • 11.4.1 China National Biotec Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 China National Biotec BCG Vaccine Sales Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 China National Biotec BCG Vaccine Sales Products Offered
  • 11.4.5 China National Biotec Recent Development
• 11.5 InterVax
  • 11.5.1 InterVax Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 InterVax BCG Vaccine Sales Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 InterVax BCG Vaccine Sales Products Offered
  • 11.5.5 InterVax Recent Development
• 11.6 Serum Institute of India
  • 11.6.1 Serum Institute of India Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Serum Institute of India BCG Vaccine Sales Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Serum Institute of India BCG Vaccine Sales Products Offered
  • 11.6.5 Serum Institute of India Recent Development
• 11.7 GreenSignal
  • 11.7.1 GreenSignal Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 GreenSignal BCG Vaccine Sales Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 GreenSignal BCG Vaccine Sales Products Offered
  • 11.7.5 GreenSignal Recent Development
• 11.8 Statens Serum Institute
  • 11.8.1 Statens Serum Institute Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 Statens Serum Institute BCG Vaccine Sales Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 Statens Serum Institute BCG Vaccine Sales Products Offered
  • 11.8.5 Statens Serum Institute Recent Development
• 11.9 Shanyao Group
  • 11.9.1 Shanyao Group Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 Shanyao Group BCG Vaccine Sales Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 Shanyao Group BCG Vaccine Sales Products Offered
  • 11.9.5 Shanyao Group Recent Development
• 11.10 Shanghai Institute of Biological Products
  • 11.10.1 Shanghai Institute of Biological Products Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 Shanghai Institute of Biological Products BCG Vaccine Sales Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 Shanghai Institute of Biological Products BCG Vaccine Sales Products Offered
  • 11.10.5 Shanghai Institute of Biological Products Recent Development

12 Future Forecast

• 12.1 BCG Vaccine Sales Market Forecast by Regions
  • 12.1.1 Global BCG Vaccine Sales Sales Forecast by Regions 2019-2025
  • 12.1.2 Global BCG Vaccine Sales Revenue Forecast by Regions 2019-2025
• 12.2 BCG Vaccine Sales Market Forecast by Product
  • 12.2.1 Global BCG Vaccine Sales Sales Forecast by Product 2019-2025
  • 12.2.2 Global BCG Vaccine Sales Revenue Forecast by Product 2019-2025
• 12.3 BCG Vaccine Sales Market Forecast by End User
• 12.4 North America BCG Vaccine Sales Forecast
• 12.5 Europe BCG Vaccine Sales Forecast
• 12.6 Asia Pacific BCG Vaccine Sales Forecast
• 12.7 Central & South America BCG Vaccine Sales Forecast
• 12.8 Middle East and Africa BCG Vaccine Sales Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 BCG Vaccine Sales Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

BCG vaccine stands for the Bacillus Calmette Guerin vaccine intended for children and adults having high prevalence of tuberculosis (TB). The vaccine prevents from various forms of tuberculosis such as TB meningitis and military.
The global BCG Vaccine Sales market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the BCG Vaccine Sales market based on company, product type, end user and key regions.

This report studies the global market size of BCG Vaccine Sales in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of BCG Vaccine Sales in these regions.
This research report categorizes the global BCG Vaccine Sales market by top players/brands, region, type and end user. This report also studies the global BCG Vaccine Sales market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Merck
Sanofi Pasteur
Japan BCG Lab
China National Biotec
InterVax
Serum Institute of India
GreenSignal
Statens Serum Institute
Shanyao Group
Shanghai Institute of Biological Products

Market size by Product
By drug type
Immune BCG
Therapy BCG
By indication
Tuberculosis
Bladder Cancer
Market size by End User
Pediatrics
Adults

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global BCG Vaccine Sales market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of BCG Vaccine Sales market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global BCG Vaccine Sales companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of BCG Vaccine Sales submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of BCG Vaccine Sales are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of BCG Vaccine Sales market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.